Ordering
Available Variants10 mL
CHJ.79842-10mL
Price
€69.12
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
10 mL | CHJ.79842-10mL | €69.12 |
Ready Made Solution, 100 mg/mL in DMSO
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C66H75Cl2N9O24 · xHCl |
|---|---|
| CAS Number | 1404-93-9 |
| Molecular Weight | 1449.25 (free base basis) |
| UNSPSC Code | 51282703 |
| NACRES | NA.85 |
Safety Information Handling visibility
| pictograms |
GHS08
 GHS08
|
|---|---|
| signalword | Danger |
| hcodes | H317,H334 |
| pcodes | P261 - P272 - P280 - P284 - P302 + P352 - P333 + P313 |
| Hazard Classifications | Resp. Sens. 1 - Skin Sens. 1 |
| Storage Class | 10 - Combustible liquids |
| wgk | WGK 2 |
| flash_point_f | 188.6 °F - closed cup |
| flash_point_c | 87 °C - closed cup |
Technical Overview & Applications Use-case context
Vancomycin hydrochloride, with a CAS number of 1404-93-9, is a glycopeptide antibiotic that has been widely used in the treatment of various bacterial infections, particularly those caused by gram-positive organisms. It is a complex molecule consisting of a heptapeptide backbone linked to a disaccharide moiety, and its mechanism of action involves inhibiting cell wall synthesis in bacteria. Vancomycin hydrochloride is commonly administered intravenously and is effective against a range of pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and Enterococcus faecalis. Due to its potential for nephrotoxicity and ototoxicity, careful monitoring of patients receiving vancomycin hydrochloride is essential, and dosage adjustments may be necessary to minimize the risk of adverse effects. As a result, vancomycin hydrochloride remains a valuable therapeutic option for the treatment of severe bacterial infections.
